相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Correction of Both NBD1 Energetics and Domain Interface Is Required to Restore ΔF508 CFTR Folding and Function
Wael M. Rabeh et al.
CELL (2012)
Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation
J. P. Clancy et al.
THORAX (2012)
Role of epithelial HCO3- transport in mucin secretion: lessons from cystic fibrosis
Paul M. Quinton
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2010)
Discovery of anti-inflammatory clinical candidate E6201, inspired from resorcylic lactone LL-Z1640-2, III
Yongchun Shen et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Discovery and development of Hsp90 inhibitors: a promising pathway for cancer therapy
James R. Porter et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2010)
Heat shock factor 1 ameliorates proteotoxicity in cooperation with the transcription factor NFAT
Naoki Hayashida et al.
EMBO JOURNAL (2010)
Insulin Reveals Akt Signaling as a Novel Regulator of Norepinephrine Transporter Trafficking and Norepinephrine Homeostasis
Sabrina D. Robertson et al.
JOURNAL OF NEUROSCIENCE (2010)
E6201, a Novel Kinase Inhibitor of Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Kinase-1 and Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Kinase Kinase-1: In Vivo Effects on Cutaneous Inflammatory Responses by Topical Administration
Kenzo Muramoto et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Correction of the ΔPhe508 Cystic Fibrosis Transmembrane Conductance Regulator Trafficking Defect by the Bioavailable Compound Glafenine
Renaud Robert et al.
MOLECULAR PHARMACOLOGY (2010)
Modulation of Akt and ERK1/2 Pathways by Resveratrol in Chronic Myelogenous Leukemia (CML) Cells Results in the Downregulation of Hsp70
Soumyajit Banerjee Mustafi et al.
PLOS ONE (2010)
Involvement of phosphatidylinositol 3-kinase in cAMP- and cGMP-induced duodenal epithelial CFTR activation in mice
Biguang Tuo et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2009)
Hsp90 transcriptionally and post-translationally regulates the expression of NDRG1 and maintains the stability of its modifying kinase GSK3β
Vanessa M. Banz et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2009)
RDEA119/BAY 869766: A Potent, Selective, Allosteric Inhibitor of MEK1/2 for the Treatment of Cancer
Cory Iverson et al.
CANCER RESEARCH (2009)
Stat1 is an inhibitor of Ras-MAPK signaling and Rho small GTPase expression with implications in the transcriptional signature of Ras transformed cells
Shuo Wang et al.
CELL CYCLE (2009)
Functional Rescue of DeltaF508-CFTR by Peptides Designed to Mimic Sorting Motifs
Patrick Kim Chiaw et al.
CHEMISTRY & BIOLOGY (2009)
High-content Functional Screen to Identify Proteins that Correct F508del-CFTR Function
Agata M. Trzcinska-Daneluti et al.
MOLECULAR & CELLULAR PROTEOMICS (2009)
Induction of Overexpression of the 27-and 70-kDa Heat Shock Proteins by Bicyclol Attenuates Concanavalin A-Induced Liver Injury through Suppression of Nuclear Factor-κB in Mice
Xiu-Qi Bao et al.
MOLECULAR PHARMACOLOGY (2009)
Cystic Fibrosis: Pathogenesis and Future Treatment Strategies
Felix A. Ratjen
RESPIRATORY CARE (2009)
CFTR Delivery to 25% of Surface Epithelial Cells Restores Normal Rates of Mucus Transport to Human Cystic Fibrosis Airway Epithelium
Liqun Zhang et al.
PLOS BIOLOGY (2009)
CFTR function and prospects for therapy
John R. Riordan
ANNUAL REVIEW OF BIOCHEMISTRY (2008)
The discovery of the benzhydroxamate MEK inhibitors CI-1040 and PD 0325901
Stephen D. Barrett et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Proteasome-dependent pharmacological rescue of cystic fibrosis transmembrane conductance regulator revealed by mutation of glycine 622
Caroline Norez et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Structural analog of sildenafil identified as a novel corrector of the F508del-CFTR trafficking defect
Renaud Robert et al.
MOLECULAR PHARMACOLOGY (2008)
Physiological fever temperature induces a protective stress response in T lymphocytes mediated by heat shock factor-1 (HSF1)
Patience Murapa et al.
JOURNAL OF IMMUNOLOGY (2007)
Sodium channels and cystic fibrosis
Scott H. Donaldson et al.
CHEST (2007)
The MEK/ERK cascade: From signaling specificity to diverse functions
Yoav D. Shaul et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2007)
Correctors of protein trafficking defects identified by a novel high-throughput screening assay
Graeme W. Carlile et al.
CHEMBIOCHEM (2007)
Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis
Xiaodong Wang et al.
CELL (2006)
Coordinating ERK/MAPK signalling through scaffolds and inhibitors
W Kolch
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
Enhanced expression of heat shock proteins in gradually dying cells and their release from necrotically dead cells
K Saito et al.
EXPERIMENTAL CELL RESEARCH (2005)
Small-molecule correctors of defective ΔF508-CFTR cellular processing identified by high-throughput screening
N Pedemonte et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Dose-finding study of the multitargeted tyrosine kinase inhibitor SU6668 in patients with advanced malignancies
BC Kuenen et al.
CLINICAL CANCER RESEARCH (2005)
Novel potent orally active selective VEGFR-2 tyrosine kinase inhibitors:: Synthesis, structure-activity relationships, and antitumor activities of N-phenyl-N′-{4-[4-quinolyloxy)phenyl}ureas
K Kubo et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Rescue of Delta F508 and other misprocessed CFTR mutants by a novel quinazoline compound
Tip W. Loo et al.
MOLECULAR PHARMACEUTICS (2005)
The F508 cystic fibrosis mutation impairs domain-domain interactions and arrests post-translational folding of CFTR
K Du et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2005)
Targeting FGFR3 in multiple myeloma: inhibition of t(4;14)-positive cells by SU5402 and PD173074
EK Grand et al.
LEUKEMIA (2004)
The glamour and gloom of glycogen synthase kinase-3
RS Jope et al.
TRENDS IN BIOCHEMICAL SCIENCES (2004)
A phase I surrogate endpoint study of SU6668 in patients with solid tumors
HQ Xiong et al.
INVESTIGATIONAL NEW DRUGS (2004)
Nanomolar affinity small molecule correctors of defective ΔF508-CFTR chloride channel gating
H Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The specificities of protein kinase inhibitors: an update
J Bain et al.
BIOCHEMICAL JOURNAL (2003)
SU6668 inhibits Flk-1/KDR and PDGFRβ in vivo, resulting in rapid apoptosis of tumor vasculature and tumor regression in mice
AD Laird et al.
FASEB JOURNAL (2002)
CFTR with a partially deleted R domain corrects the cystic fibrosis chloride transport defect in human airway epithelia in vitro and in mouse nasal mucosa in vivo
LS Ostedgaard et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Roles of the heat shock transcription factors in regulation of the heat shock response and beyond
L Pirkkala et al.
FASEB JOURNAL (2001)
Post-translational disruption of the ΔF508 cystic fibrosis transmembrane conductance regulator (CFTR)-molecular chaperone complex with geldanamycin stabilizes ΔF508 CFTR in the rabbit reticulocyte lysate
W Fuller et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Paullones are potent inhibitors of glycogen synthase kinase-3β and cyclin-dependent kinase 5/p25
M Leost et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2000)
Glycogen synthase kinase 3β negatively regulates both DNA-binding and transcriptional activities of heat shock factor 1
IJ Xavier et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
